9.75

2.01% -0.20

Avita Medical Inc (RCEL)

Overview News Price History Option Chain Financials Why RCEL Down? Discussions Forecast Stock Split

Avita Medical Inc stock is traded at $9.75, with a volume of 258.10K. It is down -2.01% in the last 24 hours and up +11.68% over the past month. Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Previous Close:

$9.95

Open:

$10.28

24h Volume:

258.10K

Relative Volume:

1.47

Market Cap:

$256.99M

Revenue:

$50.14M

Net Income/Loss:

$-35.38M

P/E Ratio:

-6.9643

EPS:

-1.4

Net Cash Flow:

$-39.46M

1W Performance:

-7.76%

1M Performance:

+11.68%

6M Performance:

+5.63%

1Y Performance:

-43.97%

1-Day Range:

$9.53

$10.40

1-Week Range:

$9.53

$11.00

52-Week Range:

$7.51

$18.93

Avita Medical Inc Stock (RCEL) Company Profile

Name

Avita Medical Inc

Sector

Healthcare (1169)

Industry

Medical Devices (154)

Phone

661-568-1317

Address

28159 AVENUE STANFORD, VALENCIA, CA

Employee

260

Twitter

@AvitaMedical

Next Earnings Date

2024-12-07

Latest SEC Filings

RCEL's Discussions on Twitter

Compare RCEL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RCEL Avita Medical Inc	9.75	256.99M	50.14M	-35.38M	-39.46M	-1.40
ABT Abbott Laboratories	134.92	234.01B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	104.49	154.20B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	382.78	146.06B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	89.94	115.42B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.30	43.23B	5.72B	4.17B	490.10M	6.97

Avita Medical Inc Stock (RCEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-24-24	Initiated	D. Boral Capital	Buy
Apr-11-24	Downgrade	BTIG Research	Buy → Neutral
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight
Mar-02-21	Initiated	Piper Sandler	Overweight
Aug-27-20	Initiated	BofA Securities	Buy
Apr-21-20	Initiated	Oppenheimer	Outperform
Mar-03-20	Initiated	BTIG Research	Buy

View All

Avita Medical Inc Stock (RCEL) Latest News

01:02 AM

Insider Buying: Robert Mcnamara Acquires 10,000 Shares of AVITA Medical Inc (RCEL) - GuruFocus.com

01:02 AM

Feb 21, 2025

AVITA Medical, Inc. (NASDAQ:RCEL) Director Robert Mcnamara Purchases 10,000 Shares - MarketBeat

Feb 21, 2025

D. Boral Capital Has Lowered Expectations for AVITA Medical (NASDAQ:RCEL) Stock Price - MarketBeat

Feb 21, 2025

Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know - MSN

Feb 21, 2025

Avita Medical director Robert McNamara purchases $100,900 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025

Feb 20, 2025

AVITA Medical, Inc. (NASDAQ:RCEL) CFO Purchases $10,250.00 in Stock - MarketBeat

Feb 20, 2025

Avita medical CFO David O'Toole acquires $9,900 in common stock - Investing.com India

Feb 20, 2025

Avita Medical director Robert McNamara purchases $100,900 in stock - Investing.com

Feb 20, 2025